Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report.
Saved in:
| Title: | Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report. |
|---|---|
| Authors: | Chu MQ; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Zhang TJ; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.; Department of Oncology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China., Feng Y; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Shao X; Department of Nuclear Medicine, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China., Ji YH; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Qian J; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Zhou JD; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Mar 31; Vol. 16, pp. 1566035. Date of Electronic Publication: 2025 Mar 31 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1566035 |
